Figure S9 from Removal of Interstitial Hyaluronan Facilitates Subcutaneous Administration and Lymphatic Delivery of Anti-CTLA4 and Improves Antitumor Efficacy

2026 Open access

Read full text
Authors: Gracia Gracia, Enyuan Cao, Daniel Yuen, Vilena D.M. Ferreira, Moore Z. Chen, Danielle Senyschyn, Justine D. Mintern, Angus P. R. Johnston, David W. Kang, Orlagh M. Feeney, Christopher J.H. Porter
DOI: 10.1158/2326-6066.31484138
Cited by: 0

Abstract

Immune cell phenotyping of TDLN from CT26/HAS tumour-bearing mice at early time points and MC38/OVA-bearing mice at 14d post-dose.

Fields of Study & Subjects

Cancer Immunotherapy and Biomarkers Proteoglycans and glycosaminoglycans research Immunotherapy and Immune Responses

Publication details

Publication date
4 March 2026
Language
EN